Concentration of Hematopoietic Progenitor Cells from Human Bone Marrow by a New Type of Blood Component Separator
- 1 August 1985
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 49 (2) , 154-160
- https://doi.org/10.1111/j.1423-0410.1985.tb00784.x
Abstract
A new type of blood component separator (BCS) was used for the isolation of hematopoietic progenitor cells from human bone marrow aspirates. The BCS was filled with 100–150 ml bone marrow and centrifuged to prepare a buffy coat. This buffy coat was isolated in 10–15% of the original bone marrow volume and contained 64 ± 8% of the nucleated cells (NC). Morphological examination revealed that the buffy coat was highly enriched for myeloblasts, promyelocytes, lymphocytes and monocytes, whereas the contamination with granulocytes was reduced to 46 ± 8% of the granulocytes initially present in the bone marrow suspension. In addition the contamination with red blood cells (RBC) was very low; the buffy coat contained only 6 ± 2% of the RBC. Furthermore it was demonstrated by means of colony assays that the buffy coat was highly enriched for hematopoietic progenitor cells. It contained 91 ± 6% of the granulocyte/monocyte progenitor cells (CFU‐GM) and 87 ± 9% of the erythroid progenitor cells (BFU‐E). These results are comparable to those obtained with continuous or semicontinuous blood cell processors. The advantages of the BCS is that it is a simple and inexpensive apparatus which fits in a normal blood bank centrifuge. It permits efficient preparation and isolation of a buffy coat from human bone marrow without substantial loss of hematopoietic progenitor cells.This publication has 14 references indexed in Scilit:
- BONE MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE-DEPLETED ALLOGENEIC BONE MARROW USING COUNTERFLOW CENTRIFUGATIONTransplantation, 1984
- REMOVAL OF NEUROBLASTOMA CELLS FROM BONE MARROW WITH MONOCLONAL ANTIBODIES CONJUGATED TO MAGNETIC MICROSPHERESThe Lancet, 1984
- A Technique for the Concentration of Nucleated Bone Marrow Cells for in vitro Manipulation or Cryopreservation Using the IBM 2991 Blood Cell ProcessorVox Sanguinis, 1983
- Rapid isolation of mononuclear cells from buffy coats prepared by a new blood cell separatorJournal of Immunological Methods, 1982
- ELIMINATION OF CARCINOMA CELLS FROM HUMAN BONE MARROWThe Lancet, 1982
- PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATIONThe Lancet, 1982
- Comparison of two methods for concentrating stem cells for cryopreservation and transplantationTransfusion, 1982
- A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processorBritish Journal of Haematology, 1982
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- THE SELECTIVE ELIMINATION OF IMMUNOLOGICALLY COMPETENT CELLS FROM BONE MARROW AND LYMPHATIC CELL MIXTURES II. MOUSE SPLEEN CELL FRACTIONATION ON A DISCONTINUOUS ALBUMIN GRADIENTTransplantation, 1968